Arvato Systems and Its Partners are Bringing the International Pharmaceutical Industry Together Once Again

5th Serialization Symposium

5th Serialization Symposium on December 12 & 13 in Berlin, Bertelsmann Premises (Copyright: shutterstock / Creative Mood / Arvato Systems)
(PresseBox) ( Gütersloh, )
  • Arvato Systems and its partners are inviting top-level pharma experts to a joint exchange at the Bertelsmann headquarters in Berlin
  • The event, which will take place on 12 and 13 December, will focus on the successful implementation of global serialization requirements within the pharmaceutical industry
For the fifth time in a row, representatives of international pharmaceutical companies and implementing serialization partners will meet for a two-day exchange within the framework of the Serialization Symposium. The two-day event will focus on the global guideline requirements for protection against counterfeit medicines in the legal supply chain. Established companies and experienced contact persons will be at the guests’ disposal for directly exchanging information.

The clock is ticking: More and more countries around the world are enacting laws and setting binding time limits on the implementation of complete serialization of prescription drugs. The European Anti-Counterfeiting Directive, 2011/62/EU, will come into force on 9 February 2019, leaving not even 450 days for pharmaceutical companies to implement the requirements.

Implementing a serialization solution means examining and adapting existing processes and systems holistically along the supply chain. Globally differing technical requirements pose additional challenges for the pharmaceutical industry.

“I am very pleased that we will be able to join our partners in bringing together industry experts to exchange knowledge and network again this year,” said Peter Koop, Vice President Healthcare at Arvato Systems. “The great response confirms the need for information on this complex and challenging topic. As experts, we are happy to provide that assistance to pharmaceutical companies.”

The 5th Serialization Symposium will be hosted by Arvato Systems and WIPOTEC-OCS together with partners Systec & Services, REA JET, Herma, Bähren Druck and ACS PharmaProtect at the Bertelsmann premises in Berlin, Germany.

After the first day of the event, all participants will be invited to a networking evening in the nearby Haus Ungarn for more in-depth discussions.

WIPOTEC-OCS is a full subsidiary of the WIPOTEC Group, a high-tech mechanical engineering company. Its dynamic, high-precision weighing and inspection solutions have been a reliable standard on production lines of leading manufacturers in the pharmaceutical, food, chemical, mail, and logistics industries for more than 25 years.

With its TQS (Traceable Quality System) machine portfolio, WIPOTEC-OCS meets all global track-and-trace requirements and is regarded as a professional industry expert with more than 1,000 successfully completed projects all over the world. TQS offers the highest level of flexibility along with extremely simple implementation and commissioning. Intuitive and very easy to use, TQS has proven to be the benchmark for universal system compatibility at the highest level. Whether the task is serialization, sealing folding boxes with tamper-evident labels, continuous aggregation, or reliable integration into packaging machines, TQS applications from WIPOTEC-OCS are first-class high-tech solutions with unrestricted compatibility with existing machine and system components and higher-level systems.

WIPOTEC-OCS is a solution provider with GS1 Germany, a voting member of the GS1 community of global healthcare solution providers, and a member of the OPEN-SCS Working Group.
Für die oben stehenden Pressemitteilungen, das angezeigte Event bzw. das Stellenangebot sowie für das angezeigte Bild- und Tonmaterial ist allein der jeweils angegebene Herausgeber (siehe Firmeninfo bei Klick auf Bild/Meldungstitel oder Firmeninfo rechte Spalte) verantwortlich. Dieser ist in der Regel auch Urheber der Pressetexte sowie der angehängten Bild-, Ton- und Informationsmaterialien.
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an